| | | | | | | | | | | | | | | | |
| | |
 | Issue Date FY: 2027 ( Subtotal = -$280,353 ) |
| | 2027 | 2026 | CINCINNATI UNIV OF | 2600 CLIFTON AVE | CINCINNATI | OH | 45220 | HAMILTON | USA | R01HL155579 | Inflammatory Mechanisms in Post Burn Anemia of Critical Illness | 000 | 5 | NIH | 10/14/2026 | $0 |
| | 2027 | 2026 | CINCINNATI UNIV OF | 2600 CLIFTON AVE | CINCINNATI | OH | 45220 | HAMILTON | USA | UL853311 | Integrating Behavioral Health into Primary Care through Telehealth Evidence-Based Telehealth Network | 01 | 3 | HRSA | 10/20/2026 | $0 |
| | 2027 | 2026 | CINCINNATI UNIV OF | 2600 CLIFTON AVE | CINCINNATI | OH | 45220 | HAMILTON | USA | R01HL183368 | EMbArK: Empagliflozin Treatment of Ischemic with Non-Obstructive Coronary Arteries (INOCA) | 000 | 1 | NIH | 10/15/2026 | $0 |
| | 2027 | 2026 | CINCINNATI UNIV OF | 2600 CLIFTON AVE | CINCINNATI | OH | 45220 | HAMILTON | USA | U01NS110772 | FVIIa for Acute hemorrhagic Stroke Administered at Earliest Time (FASTEST) Trial | 000 | 5 | NIH | 10/13/2026 | $0 |
| | 2027 | 2026 | CINCINNATI UNIV OF | 2600 CLIFTON AVE | CINCINNATI | OH | 45220 | HAMILTON | USA | U24NS107241 | Ohio Valley Regional Coordinating Center for NINDS Stroke Trial Network | 000 | 8 | NIH | 11/9/2026 | $0 |
| | 2027 | 2026 | CINCINNATI UNIV OF | 2600 CLIFTON AVE | CINCINNATI | OH | 45220 | HAMILTON | USA | R01CA259845 | Fatty acid metabolism regulates ferroptosis in mutant KRAS lung cancer | 000 | 5 | NIH | 11/10/2026 | $0 |
| | 2027 | 2026 | CINCINNATI UNIV OF | 2600 CLIFTON AVE | CINCINNATI | OH | 45220 | HAMILTON | USA | R01OH012668 | Immunological Tools for Hypersensitivity Pneumonitis in Machinists | 01 | 1 | CDC | 10/30/2026 | $0 |
| | 2027 | 2026 | CINCINNATI UNIV OF | 2600 CLIFTON AVE | CINCINNATI | OH | 45220 | HAMILTON | USA | R01NR020184 | Telehealth Assessment and Skill-Building Intervention for Stroke Caregivers (TASK III) | 000 | 5 | NIH | 11/2/2026 | $0 |
| | 2027 | 2026 | CINCINNATI UNIV OF | 2600 CLIFTON AVE | CINCINNATI | OH | 45220 | HAMILTON | USA | R21EB036615 | Aptamer tagging with redox quenchers: a critical breakthrough in the sensitivity of continuous electrochemical protein monitoring | 000 | 2 | NIH | 10/27/2026 | $0 |
| | 2027 | 2026 | CINCINNATI UNIV OF | 2600 CLIFTON AVE | CINCINNATI | OH | 45220 | HAMILTON | USA | R01CA260749 | UPR Activators for Cancer Therapy | 000 | 5 | NIH | 10/8/2026 | $0 |
| | 2027 | 2026 | CINCINNATI UNIV OF | 2600 CLIFTON AVE | CINCINNATI | OH | 45220 | HAMILTON | USA | R21HL177541 | Engineering RNA biodevices for precise modulation of fibroblasts to boost cardiac reprogramming | 000 | 2 | NIH | 11/13/2026 | $0 |
| | 2027 | 2025 | CINCINNATI UNIV OF | 2600 CLIFTON AVE | CINCINNATI | OH | 45220 | HAMILTON | USA | R37NS122141 | Neuromodulatory regulation of synaptic plasticity in spinal nociceptive circuits | 000 | 4 | NIH | 10/20/2026 | $0 |
| | 2027 | 2025 | CINCINNATI UNIV OF | 2600 CLIFTON AVE | CINCINNATI | OH | 45220 | HAMILTON | USA | R01HL157176 | Sox9 Regulation of Fibroblast Activation and Pulmonary Fibrosis | 000 | 6 | NIH | 10/21/2026 | $0 |
| | 2027 | 2025 | CINCINNATI UNIV OF | 2600 CLIFTON AVE | CINCINNATI | OH | 45220 | HAMILTON | USA | R01HL134801 | WT1 REGULATION OF PULMONARY FIBROSIS | 000 | 9 | NIH | 11/8/2026 | -$3,434 |
| | 2027 | 2024 | CINCINNATI UNIV OF | 2600 CLIFTON AVE | CINCINNATI | OH | 45220 | HAMILTON | USA | R01ES034049 | Childhood and In utero Exposure to Organophosphate and Replacement Brominated Flame Retardants and Child Respiratory Outcomes | 000 | 3 | NIH | 11/16/2026 | -$644 |
| | 2027 | 2024 | CINCINNATI UNIV OF | 2600 CLIFTON AVE | CINCINNATI | OH | 45220 | HAMILTON | USA | R21EB033874 | Breakthrough Blocking-Layer Stability for Broader Clinical Utility of Continuous Aptamer Biosensors | 000 | 3 | NIH | 11/16/2026 | -$40,983 |
| | 2027 | 2024 | CINCINNATI UNIV OF | 2600 CLIFTON AVE | CINCINNATI | OH | 45220 | HAMILTON | USA | R21AI178573 | Barcode screening of essential protein kinases in the life cycle progression of Trypanosoma cruzi | 000 | 2 | NIH | 11/3/2026 | -$191 |
| | 2027 | 2024 | CINCINNATI UNIV OF | 2600 CLIFTON AVE | CINCINNATI | OH | 45220 | HAMILTON | USA | R24ES028527 | Fernald Community Cohort: Research Resource for Environmental Epidemiology | 000 | 5 | NIH | 11/3/2026 | -$10,516 |
| | 2027 | 2024 | CINCINNATI UNIV OF | 2600 CLIFTON AVE | CINCINNATI | OH | 45220 | HAMILTON | USA | T32ES007250 | Environmental Carcinogenesis and Mutagenesis | 000 | 35 | NIH | 11/3/2026 | -$218,618 |
| | 2027 | 2024 | CINCINNATI UNIV OF | 2600 CLIFTON AVE | CINCINNATI | OH | 45220 | HAMILTON | USA | K23HL151872 | Platelets and Hemostatic Factors as Facilitators of the Inflammatory Response Following Transcatheter Aortic Valve Replacement | 000 | 5 | NIH | 11/5/2026 | -$5,968 |
| | 2027 | 2023 | CINCINNATI UNIV OF | 2600 CLIFTON AVE | CINCINNATI | OH | 45220 | HAMILTON | USA | R01NS113917 | Gene Therapy Targeting of CNTFRalpha and CLC in Muscle to Treat ALS | 000 | 5 | NIH | 10/28/2026 | $0 |
|
 | Issue Date FY: 2026 ( Subtotal = $91,252,989 ) (Continued on the next page) |
| | 2026 | 2026 | CINCINNATI UNIV OF | 2600 CLIFTON AVE | CINCINNATI | OH | 45220-2872 | HAMILTON | USA | R01NS134804 | Developing multi-cue piezoelectric PVDF-TrFE biomaterials for peripheral nerve repair | 000 | 3 | NIH | 1/31/2026 | $414,682 |
| | 2026 | 2026 | CINCINNATI UNIV OF | 2600 CLIFTON AVE | CINCINNATI | OH | 45220 | HAMILTON | USA | R01NS137887 | No REST for 5-HT Neurons Following Traumatic Brain Injury | 000 | 3 | NIH | 8/7/2026 | $405,000 |
| | 2026 | 2026 | CINCINNATI UNIV OF | 2600 CLIFTON AVE | CINCINNATI | OH | 45220 | HAMILTON | USA | UG1DA013732 | The Ohio Valley Node of the Clinical Trials Network | 003 | 27 | NIH | 3/30/2026 | $7,976,087 |
| | 2026 | 2026 | CINCINNATI UNIV OF | 2600 CLIFTON AVE | CINCINNATI | OH | 45220 | HAMILTON | USA | UG1DA013732 | The Ohio Valley Node of the Clinical Trials Network | 002 | 27 | NIH | 3/6/2026 | $9,019,558 |
| | 2026 | 2026 | CINCINNATI UNIV OF | 2600 CLIFTON AVE | CINCINNATI | OH | 45220 | HAMILTON | USA | UG1DA013732 | The Ohio Valley Node of the Clinical Trials Network | 004 | 27 | NIH | 4/20/2026 | $0 |
| | 2026 | 2026 | CINCINNATI UNIV OF | 2600 CLIFTON AVE | CINCINNATI | OH | 45220 | HAMILTON | USA | UG1DA013732 | The Ohio Valley Node of the Clinical Trials Network | 004 | 27 | NIH | 4/20/2026 | $0 |
| | 2026 | 2026 | CINCINNATI UNIV OF | 2600 CLIFTON AVE | CINCINNATI | OH | 45220 | HAMILTON | USA | UG1DA013732 | The Ohio Valley Node of the Clinical Trials Network | 003 | 27 | NIH | 3/30/2026 | -$7,976,087 |
| | 2026 | 2026 | CINCINNATI UNIV OF | 2600 CLIFTON AVE | CINCINNATI | OH | 45220 | HAMILTON | USA | R35GM149538 | Novel regulators of macrophage function to repair sterile inflammation-induced heart injury | 000 | 4 | NIH | 4/2/2026 | $440,236 |
| | 2026 | 2026 | CINCINNATI UNIV OF | 2600 CLIFTON AVE | CINCINNATI | OH | 45220 | HAMILTON | USA | R01CA279962 | Genetically-encoded molecular imaging of genome-edited immune cells | 000 | 3 | NIH | 8/13/2026 | $1,375,031 |
| | 2026 | 2026 | CINCINNATI UNIV OF | 2600 CLIFTON AVE | CINCINNATI | OH | 45220 | HAMILTON | USA | R21AG085052 | The cell-specific neurodegenerative potential of mitochondria post-traumatic brain injury | 000 | 3 | NIH | 7/7/2026 | $239,095 |
| | 2026 | 2026 | CINCINNATI UNIV OF | 2600 CLIFTON AVE | CINCINNATI | OH | 45220 | HAMILTON | USA | R01AG104074 | Examining the contribution of plasma lipidomics, neighborhood deprivation and cerebral small vessel disease to vascular cognitive impairment and dementia | 000 | 1 | NIH | 9/14/2026 | $845,769 |
| | 2026 | 2026 | CINCINNATI UNIV OF | 2600 CLIFTON AVE | CINCINNATI | OH | 45220 | HAMILTON | USA | F30DC023760 | Sustained delivery of siRNA-lipid nanoparticles via polymer implant for vocal fold scarring | 001 | 1 | NIH | 9/2/2026 | $0 |
| | 2026 | 2026 | CINCINNATI UNIV OF | 2600 CLIFTON AVE | CINCINNATI | OH | 45220 | HAMILTON | USA | F30DC023760 | Sustained delivery of siRNA-lipid nanoparticles via polymer implant for vocal fold scarring | 000 | 1 | NIH | 9/2/2026 | $43,660 |
| | 2026 | 2026 | CINCINNATI UNIV OF | 2600 CLIFTON AVE | CINCINNATI | OH | 45220 | HAMILTON | USA | R01GM156796 | Fundamental properties of circadian rhythms | 000 | 2 | NIH | 7/24/2026 | $380,089 |
| | 2026 | 2026 | CINCINNATI UNIV OF | 2600 CLIFTON AVE | CINCINNATI | OH | 45220 | HAMILTON | USA | R01HL185075 | Mechanisms of Smooth Muscle Cell Contraction in Asthma | 000 | 1 | NIH | 9/17/2026 | $696,625 |
| | 2026 | 2026 | CINCINNATI UNIV OF | 2600 CLIFTON AVE | CINCINNATI | OH | 45220 | HAMILTON | USA | R50CA305011 | NCI-Sponsored Leadership Focused on Clinical Trial Enrollment | 000 | 1 | NIH | 9/7/2026 | $240,272 |
| | 2026 | 2026 | CINCINNATI UNIV OF | 2600 CLIFTON AVE | CINCINNATI | OH | 45220 | HAMILTON | USA | U54HL188781 | Clinical Trial Readiness for Rare Lung Diseases | 000 | 1 | NIH | 9/4/2026 | $1 |
| | 2026 | 2026 | CINCINNATI UNIV OF | 2600 CLIFTON AVE | CINCINNATI | OH | 45220 | HAMILTON | USA | U54HL188781 | Clinical Trial Readiness for Rare Lung Diseases | 000 | 1 | NIH | 9/4/2026 | $1,757,693 |
| | 2026 | 2026 | CINCINNATI UNIV OF | 2600 CLIFTON AVE | CINCINNATI | OH | 45220 | HAMILTON | USA | U54HL188781 | Clinical Trial Readiness for Rare Lung Diseases | 000 | 1 | NIH | 9/4/2026 | $1 |
| | 2026 | 2026 | CINCINNATI UNIV OF | 2600 CLIFTON AVE | CINCINNATI | OH | 45220 | HAMILTON | USA | U01CA317558 | Exploiting Lipid Metabolism and Dietary Interventions to Sensitize KRAS-Driven Tumors to Ferroptosis | 001 | 1 | NIH | 9/18/2026 | $0 |
| | 2026 | 2026 | CINCINNATI UNIV OF | 2600 CLIFTON AVE | CINCINNATI | OH | 45220 | HAMILTON | USA | U01CA317558 | Exploiting Lipid Metabolism and Dietary Interventions to Sensitize KRAS-Driven Tumors to Ferroptosis | 000 | 1 | NIH | 8/31/2026 | $672,300 |
| | 2026 | 2026 | CINCINNATI UNIV OF | 2600 CLIFTON AVE | CINCINNATI | OH | 45220 | HAMILTON | USA | R35GM161787 | Structural/functional characterization of TGFB superfamily signaling and regulation | 000 | 1 | NIH | 4/8/2026 | $756,933 |
| | 2026 | 2026 | CINCINNATI UNIV OF | 2600 CLIFTON AVE | CINCINNATI | OH | 45220 | HAMILTON | USA | R00AR083486 | Novel models to study dorsal root ganglion neurons in knee osteoarthritis pain | 000 | 3 | NIH | 9/4/2026 | $249,000 |
| | 2026 | 2026 | CINCINNATI UNIV OF | 2600 CLIFTON AVE | CINCINNATI | OH | 45220 | HAMILTON | USA | R21MD020828 | Empowering Nutrition Through Graphic-Style Stories: Co-Designing an Acceptable and Feasible Community-Based Program with Adults with Intellectual and Developmental Disabilities and Their Caregivers | 000 | 1 | NIH | 8/31/2026 | $202,500 |
| | 2026 | 2026 | CINCINNATI UNIV OF | 2600 CLIFTON AVE | CINCINNATI | OH | 45220 | HAMILTON | USA | R01EB038223 | Advancing Chemically-Modified Aptamers for Ultra-Sensitive Biomonitoring at the Picomolar-to-Nanomolar Scale | 000 | 1 | NIH | 9/1/2026 | $398,400 |
| | 2026 | 2026 | CINCINNATI UNIV OF | 2600 CLIFTON AVE | CINCINNATI | OH | 45220 | HAMILTON | USA | K23HL183818 | Mapping Activated Microglia and Their Effect on Cognitive Deficits in Adults with Sickle Cell Disease | 000 | 1 | NIH | 4/8/2026 | $186,613 |
| | 2026 | 2026 | CINCINNATI UNIV OF | 2600 CLIFTON AVE | CINCINNATI | OH | 45220 | HAMILTON | USA | R13DC023787 | Ultra SLP: Evidence and Practice in Ultrasound Feedback Therapy | 000 | 1 | NIH | 6/30/2026 | $52,000 |
|